MedTrace Logo

Pediatric and Adolescent Patellar Instability

NCT02333825 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 240

Last updated 2026-02-13

No results posted yet for this study

Summary

This is a multi-center, randomized controlled clinical trial, the purpose of which is to determine if patients age 25 and younger who undergo medial patellofemoral ligament (MPFL) reconstruction have lower rates of recurrent instability compared to those treated non-operatively. The MPFL is a ligament that stabilizes the kneecap, and maintains its proper position in the groove on the femur (thighbone). Instability refers to a situation in which the kneecap moves out of place, or dislocates. When instability is recurrent, it occurs more than once in the same knee.

Conditions

  • Patellar Instability

Interventions

PROCEDURE

Medial patellofemoral ligament reconstruction surgery

Medial patellofemoral ligament reconstruction surgery using hamstring autograft

OTHER

Physical therapy and rehabilitation

A standardized physical therapy and rehabilitation program to be administered and guided by rehab specialists

Sponsors & Collaborators

  • Mayo Clinic

    collaborator OTHER

  • Oregon Health and Science University

    collaborator OTHER

  • Inova Medical Group

    collaborator UNKNOWN

  • Hospital for Special Surgery, New York

    lead OTHER

Principal Investigators

  • Beth E Shubin Stein, MD · Hospital for Special Surgery, New York

  • Jacqueline Munch, MD · Oregon Health and Science University Hospital

  • Diane Dahm, MD · Mayo Clinic

  • Robin V West, MD · Inova Sports Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Model
PARALLEL

Eligibility

Min Age
8 Years
Max Age
25 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-12-31
Primary Completion
2026-12-31
Completion
2026-12-31

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02333825 on ClinicalTrials.gov